Digestive Diseases and Sciences

, Volume 43, Issue 9, pp 1931–1937 | Cite as

Role of Splenectomy in Human Liver Transplantation Under Modern-Day Immunosuppression

  • Farokh Samimi
  • William D. Irish
  • Bijan Eghtesad
  • Anthony J. Demetris
  • Thomas E. Starzl
  • John J. Fung


Between January 1987 and October 1991, 1466patients underwent consecutive Orthotopic LiverTransplantation (OLTx) at the University of Pittsburgh.Forty of these patient's had concomitant splenectomywith OLTx. These patients were compared to 147randomly selected OLTx patients without splenectomywithin the same time period. One-year patient and graftsurvival (PS and GS) were lower in splenectomized (Splx) patients compared to nonsplenectomized(non-Splx) patients (59% vs 86% PS, 55% vs 80% GS,respectively). One-month and one-year patient mortalityin the Splx group was higher than in the non-splxpatients (20% vs 3.4%, P < 0.001 for one month; 40%vs 14.3%, P = 0.003 for one year, respectively).One-month and one-year sepsis-related mortality was alsohigh in Splx patients (17.5% vs 2.7%, P = 0.0022, for one month, and 30% vs 11.5%, P = 0.0043,for one year, respectively). We conclude thatconcomitant splenectomy with OLTx has a significantlyhigher patient mortality mainly due to its septiccomplications and, at present, unless there is a specificindication for a splenectomy, the routine addition ofthis procedure to liver allograft surgery would not berecommended.



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Starzl TE, Marchioro TL, Talmage DW, Waddell WR: Splenectomy and thymectomy in human renal homotransplantation. Proc Soc Exp Biol Med 113:92, 1963Google Scholar
  2. 2.
    Starzl TE: Role of excision of lymphoid masse s in attenuating the rejection process. InExperience in Renal Transplantation. Starzl TE (ed). Philadelphia, WB Saunders 1964, 126Google Scholar
  3. 3.
    Hume DM, Mage e JH, Kauffman HM, Bower JD, Lee HM, Cleveland RJ, Prout GR: Transplantation results at the Med-ical College of Virginia, Summary through September 1963. Transplantation 2:164, 1964Google Scholar
  4. 4.
    Gleason RE, Murray JE: Report from kidney transplant registry: Analysis of variables in the function of human kidney transplants I. Blood group compatibility and splenectomy. Transplantation 5:343, 1967Google Scholar
  5. 5.
    Pierce JC, Hume DM: The effect of splenectomy on the survival of first and second renal homotransplants in man. Surg Gynecol Obstet 127:1300–1306, 1968PubMedGoogle Scholar
  6. 6.
    Krivit W, Giebink GS, Leonard A: Overwhelming postsplenectomy infection. Surg Clin North Am 59:223, 1979PubMedGoogle Scholar
  7. 7.
    Stuart FP, Reckard CR, Ketel BL, Schulak JA: Effect of splenectomy on first cadaver kidney transplants. Ann Surg 192:553, 1980PubMedGoogle Scholar
  8. 8.
    Fryd DS, Sutherland DER, Simmons RL, Ferguson RM, Rjellstrand CM, Najarian JS: Results of a prospective randomized study on the effects of splenectomy versus no splenectomy in renal transplant patients. Transplant Proc 13:48, 1981PubMedGoogle Scholar
  9. 9.
    Peters TG, Williams JN, Harmon HC, Britt LG: Splenectomy and death in renal transplant patients. Arch Surg 118:795, 1983PubMedGoogle Scholar
  10. 10.
    Lewis RM, Banowsky LHW, Nicastro-Lutton JJ, Cruz AB, Saunders PH: Selective post transplant splenectomy in recipients of cadaveric renal allografts. Transplantation 36:198, 1983PubMedGoogle Scholar
  11. 11.
    Mozes MF, Spigos DG, Thomas PA, Nisikawa RA, Cohen C, Johnasson O: Antilymphocyte globulin (ALG) and splenectomy or partial splenicembolization (PSE): Evidence for a synergistic beneficial effect on cadaver renal allograft survival. Transplant Proc 15:613, 1983Google Scholar
  12. 12.
    Krakauerr H, Spees EK, Vaughn WK, Grauman JS, Summe JP, Bailey RC: Assessment of prognostic factors and projection of outcome s in renal transplantation. Transplantation 36:372, 1983PubMedGoogle Scholar
  13. 13.
    Zincke H, Engen DE, Sterioff S, McDonald MW, Frohnert PP, Johnson WJ: Improving results in primary diabetic renal transplantation. Transplant Proc 16:372, 1984Google Scholar
  14. 14.
    Alexander JN, First MR, Majeski JA, Munda R, Fidler JP, Morris MJ, Suttman MP: The late adverse effect of splenectomy on patient survival following cadaveric renal transplantation. Transplantation 37:467, 1984PubMedGoogle Scholar
  15. 15.
    Lebeau G, Yanaga K, Marsh JW, Tzakis AG, Makowka L, Gordon RD, Todo S, Stieber AC, Iwatsuki S, Starzl TE: Analysis of surgical complication after 397 hepatic transplantations. Surg Gyne col Obstet 170:317, 1990Google Scholar
  16. 16.
    Sutherland DER, Fryd DS, SO SKS, Bentley FR, Asche r NL, Simmons RL, Najarian JS: Long-term effects of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation 38:619, 1984PubMedGoogle Scholar
  17. 17.
    Lemeohow S, Hosme r DW, Klor J, Lwanga SK: Adequacy of Sample Size in Health Studies, New York, Wiley 1990Google Scholar
  18. 18.
    Kahn L, Sempos C: Statistical Methods in Epidemiology. New York, Oxford University Press, 1989, p 85Google Scholar
  19. 19.
    Lende M, Santiago-Delphin EA, Lavergne J: Immunobiological consequence s of splenectomy: A review. J Surg Res 40:85, 1986CrossRefPubMedGoogle Scholar
  20. 20.
    Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ: Migration patterns of dendritic cells in the mouse. J Exp Med 167:646, 1988CrossRefPubMedGoogle Scholar
  21. 21.
    Meiser BM, Morris RE: The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation. Transplantation 51:690, 1991PubMedGoogle Scholar
  22. 22.
    Shaked A, Busutti RW: Liver transplantation in patients with portal vein thrombosis and central portocaval shunts. Ann Surg 214:696, 1991PubMedGoogle Scholar
  23. 23.
    Yamaguchi Y, Halprin EC, Harland RC, Wyble C, Bollinger RR: Signifi cant prolonging of hamster liver transplant survival in Lewis rats by total lymphoid irradiation, cyclosporine, and splenectomy. Transplantation 49:13, 1990PubMedGoogle Scholar
  24. 24.
    Monden M, Valdivia LA, Gotoh M, Kubota N, Hosuike Y, Nakano Y, Okamura J, Mori T: A crucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine. Surgery 105:535, 1989PubMedGoogle Scholar
  25. 25.
    Jiang H, Takahara S, Kyo M, Hashimoto M, Takano Y, Kameoka H, Moutabarik A, Kokado Y, Ishibashi M, Okuyama A, Sonoda T: Prolonged cardiac allograft survival in sensitized rats by low-dose FK506 in combination with splenectomy. Transplant Proc 23:3291, 1991PubMedGoogle Scholar
  26. 26.
    Johnson EM, Fische l RJ, Boyle EM, Matas AJ, Bolman RM: Plasma exchange, splenectomy, and cyclophosphamide for natural antibody removal: Kidneys and xenograft survival. Transplant Proc 24:701, 1992PubMedGoogle Scholar
  27. 27.
    Yamaguchi Y, Halperin EC, Harland RC, Wyble C, Bollinger RR: Significant prolonging of hamster liver transplant survival in Lewis rats by total lymphoid irradiation, cyclosporine, and splenectomy. Transplantation 49:13, 1990PubMedGoogle Scholar
  28. 28.
    Araneda D, Carobbi A, Thomas J, Thomas F: Paradoxical effects of xenografts in the nude rat: Effects of splenectomy on aberrant graft rejection. Transplant Proc 24:195, 1992Google Scholar
  29. 29.
    Carobbi A, Araneda D, Quarantilo P, Thomas JM, Thomas FT: Syne rgism of splenectomy and immunosuppressive drugs in prolonging of cardiac xenograft survival. Transplant Proc 24:527, 1992PubMedGoogle Scholar
  30. 30.
    Lim SML, Kohno H, White DJG: Splenectomy abrogates the ability of thorasic duct lymphocyte of tolerant rats to transfer suppression. Transplant Proc 21:480, 1989PubMedGoogle Scholar
  31. 31.
    Rai GS, Wilkinson R, Taylor RMR, Uldall PR, Derr DN: Adverse effect of splenectomy in renal transplantation. Clin Nephrol 9:194, 1978PubMedGoogle Scholar
  32. 32.
    Shofer FS, London WT, Lyons P, Simmonian SJ, Burke JF, Jarre l BE, Grossman RA, Barke r CF: Adverse effect of splenectomy on the survival of patients with more than one kidney transplant. Transplantation 42:473, 1986PubMedGoogle Scholar
  33. 33.
    Valdivia LA, Monden M, Gotoh M, Hasuike Y, Kubota N, Ichikawa T, Okamura J, Mori T: Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation 44(6):759–763, 1987PubMedGoogle Scholar
  34. 34.
    Aradeda D, Carobbi A, Patselas T, Thomas F, Thomas J: Timing of splenectomy is critical in prolongation of cardiac xenografts. Transplant Proc 24:523, 1992PubMedGoogle Scholar
  35. 35.
    Murase N, Starzl TE, Demetris AJ, Valdivia L, Tanabe M, Cramer D, Makowka L: Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 55:701–708, 1993PubMedGoogle Scholar
  36. 36.
    Megison SM, McMullin ND, Andrews WS: Selective use of splenectomy after liver transplantation in children. J Pediatr Surg 25:881, 1990PubMedGoogle Scholar
  37. 37.
    Starzl TE, Demetris AJ: Differential Diagnosis of Graft Dysfunction in Liver Transplantation. Chicago, Yearbook Medical Publishers, pp 85–99, 1990Google Scholar
  38. 38.
    Deme tris AJ, Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartman G, Murase N, Todo S, Bronsther O, Mane z R, Fung JJ, Iwatsuki S, Starzl TE: A clinicopathological study of human liver allograft recipients harboring performed IgG lymphocytotoxic antibodies. Hepatology 16:671–681, 1992PubMedGoogle Scholar
  39. 39.
    Starzl TE, Lerne r RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI: Schwartzman reaction after human renal transplantation. N Engl J Med 278:642–648, 1968PubMedGoogle Scholar
  40. 40.
    Starzl TE, Valdivia LA, Murase N, Demetris AJ, Fontes P, Rao AS, Mane z R, Marino I, Todo S, Thomson AW, Fung JJ: The biologic basis of and strategie s for clinical xenotransplantation. Immunol Rev 141:213–244, 1994PubMedGoogle Scholar
  41. 41.
    Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, Demetris AJ, Kobayashi M, Todo Suite 130, Tzakis AG, Fung JJ, Starzl TE: The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 53:400–406, 1992PubMedGoogle Scholar
  42. 42.
    Takaya S, Iwaki Y, Starzl TE: Liver Transplantation in positive cytotoxic crossmatch cases using FK506, high dose steroids, and prostaglandin E1. Transplantation 54:927–930, 1992PubMedGoogle Scholar
  43. 43.
    Takaya S, Doyle H, Todo S, Irish W, Fung JJ, Starzl TE: Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc 27:1862–1867, 1995PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • Farokh Samimi
  • William D. Irish
  • Bijan Eghtesad
  • Anthony J. Demetris
  • Thomas E. Starzl
  • John J. Fung

There are no affiliations available

Personalised recommendations